2 unknown, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Completed 1 |
Follow Amarantus BioScience Holdings, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Autologous Engineered Skin Substitute to Treat Partial- and Full-Thickness Burn Wounds Autologous Engineered Skin Substitute, Split-Thickness Autograft (AG) - Thermal Injury, Deep Partial-Thickness Burn | Phase 2 | Unknown | Amarantus BioScience Holdings, Inc. | 10 | 2016-09-01 | 2016-08-31 |
| A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients Eltoprazine HCl, Placebo - Parkinson's Disease, Dyskinesia | Phase 2 | Unknown | Amarantus BioScience Holdings, Inc. | 60 | 2015-05-01 | 2016-04-22 |
| Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults Eltoprazine, Placebo - Cognitive Impairment, Schizophrenia | Phase 2 | Completed | Amarantus BioScience Holdings, Inc. | 31 | 2011-08-01 | 2015-04-14 |
Burns (1) · Cognitive Dysfunction (1) · Dyskinesias (1) · Parkinson Disease (1) · Schizophrenia (1)
eltoprazine (1)
United States (3)
Charlotte Keywood, MBBS,MRCP, (1) · John G Csernansky, MD (1) · Michael Peck, MD (1)